-74.72% Operating results for each business segment are shown below: 1. Manufacturing and Selling of Special Cutting Tools unit: THB million 2019 2018 Change (THB million) Change (%) Revenue from External
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
loss profit increased by 5.38 million Baht For the following reasons; The result of the 3rd quarter of 2019 (Unit: Million Baht) Biodiesel Edible oil By-product Palm oil refining service Vessel operating
ratios as stipulated by such loan agreements. (6) Factors Having Impact on Future Operating Results The Corporate Group expects that the overall market for construction materials during the second half of
agreements. (6) Factors Having Impact on Future Operating Results The Corporate Group expects that the overall market for construction materials during the second half of this year will be weakening due to
warrants exercise LTM 3Q18 Operating Cash Flow of $1,037 million Net Operating D/E ratio 0.53x; Rating Upgrade to AA- with “Stable Outlook” 2019 Guidance reaffirmed; attractive and accretive production
-2495-1366 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the fourth quarter and year ended December 31, 2018 comparing operating performance and
@kiatnakin.co.th Tel. +66-2841-5925 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the second quarter and six months ended June 30, 2018 comparing operating
. +66-2841-5925 Website: www.kiatnakin.co.th http://www.kiatnakin.co.th/ 2 Management Discussion and Analysis (MD&A) For the second quarter and six months ended June 30, 2018 comparing operating
operating performance and financial position for the third quarter and nine months ended September 30, 2018 with those of 2017. This report discusses principal changes in the unreviewed consolidated financial